Skip to main content
Main navigation
Home
About pCPA
Who We Are
Governance
Strategic Plan
Whats New at the pCPA
FAQs
Negotiations
Recent Updates
Forms and Publications
Brand Name Drugs
Negotiations Status
Negotiation Process
Generic Drugs
Biologics/Biosimilars
Contact Us
EN
FR
Remsima SC (infliximab)
pCPA File Number:
21440
Negotiation Status:
Concluded without agreement
Indication(s):
Rheumatoid Arthritis
Sponsor/Manufacturer:
Celltrion Healthcare Canada Ltd.
CADTH Project Number:
SR0659
pCPA Engagement Letter Issued:
2021-06-04
Negotiation Process Concluded:
2022-03-10